PRDX3 and neoplasm: However, there is evidence that downregulation of Prdx3 led to enhancing the tumor malignancies and invasiveness in certain cancers, so the targeting of Prdx3 for effective drug development requires further research and it will be beneficial to target the signaling pathway instead of a single factor.